Q20R (p.Gln20Arg) variant of PAH (Phenylalanine-4-hydroxylase)

Q20R (p.Gln20Arg) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in PAH deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.59 / 1. The record also includes population frequency data and structural context.

Q20R (p.Gln20Arg) variant details